对埃塞俄比亚患者的不利公众态度:系统性审查和元分析研究
Mengesha Srahbzu Biresaw1, Anggi Irawan1, Peter Halász2,3
1Doctoral School of Mental Health Sciences, Semmelweis University, Budapest, Hungary.
Epilepsia open
|July 3, 2023
概括
超过一半的埃塞俄比亚人对患者有不利的态度 (UPATPWE). 亲眼目睹发作会增加这种风险,强调需要进行公共卫生教育和宣传活动.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 社会科学 社会科学 社会科学
背景情况:
- 是一种神经系统疾病,具有显著的社会和心理影响.
- 公众对的态度可能导致耻辱,歧视和社会排斥.
- 了解公众的看法对于开发有效的干预措施至关重要.
研究的目的:
- 确定埃塞俄比亚对患者的不利公众态度 (UPATPWE) 的综合流行情况.
- 在埃塞俄比亚背景下识别与UPATPWE相关的因素.
- 为有针对性的公共卫生战略提供证据.
主要方法:
- 发表的研究报告的系统审查和元分析.
- 在PubMed/Medline,Science Direct,Cochrane图书馆,谷歌学者和PsycINFO (2022年12月) 中进行了搜索.
- 使用随机效应元分析模型,遵循PRISMA指南.
主要成果:
- 包括9项研究 (访问了104篇论文).
- 在埃塞俄比亚,UPATPWE的综合流行率为52.06% (95% CI: 37.54, 66.59).
- 见证一次发作与UPATPWE相关 (AOR = 2.70 [95% CI: 1.13, 6.46]). 发作与UPATPWE有关.
结论:
- 埃塞俄比亚人口中很大一部分人对患者有不利的态度.
- 这些态度导致了诸如驱逐和缺乏适当治疗等负面结果.
- 调查结果强调需要全面的健康教育和公众宣传活动.
相关概念视频
Epilepsy and Seizures: Overview
217
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
217
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Antiepileptic Drugs: Glutamate Antagonists
427
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
427
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
350
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
350
Antiepileptic Drugs: GABAergic Pathway Potentiators
467
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
467
Electroconvulsive Therapy
75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75


